BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Withdrawn
- Conditions
- CholangitisBacteremia
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT02543957
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Complementary Combination Therapy for Cocaine Dependence
Phase 1
Completed
- Conditions
- Cocaine Dependence
- Interventions
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 45
- Registration Number
- NCT02538744
- Locations
- 🇺🇸
Michael Debakey VA Medical Center, Houston, Texas, United States
The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.
Terminated
- Conditions
- Adenomatous Polyp of Colon
- Interventions
- Other: Segmental withdrawal
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 232
- Registration Number
- NCT02538406
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
- Conditions
- Hyperinsulinemic Hypoglycemia, PersistentCongenital HyperinsulinismPersistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
- First Posted Date
- 2015-08-26
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT02533219
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Urinary Biomarkers of OI Pathobiology
Active, not recruiting
- Conditions
- Osteogenesis Imperfecta
- First Posted Date
- 2015-08-24
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT02531087
- Locations
- 🇨🇦
Shriners Hospital for Children, Montreal, Quebec, Canada
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Oregon Health Science University, Portland, Oregon, United States
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
Phase 2
Completed
- Conditions
- Infant, Small for Gestational AgeComplication of PrematurityIntrauterine Growth RestrictionPremature Birth of NewbornFetal MacrosomiaHypoglycemiaNeonatal Hypoglycemia
- Interventions
- Dietary Supplement: 40% Dextrose gel
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 236
- Registration Number
- NCT02523222
- Locations
- 🇺🇸
Ben Taub Harris Health Hospital, Houston, Texas, United States
Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based Intervention
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Diabetes Strengths Study
- First Posted Date
- 2015-07-29
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 172
- Registration Number
- NCT02510664
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Other: ambient airOther: 0.5% CO2
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 6
- Registration Number
- NCT02493985
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
Phase 1
Recruiting
- Conditions
- Myelodysplastic SyndromeAcute Myeloid Leukemia
- Interventions
- Biological: MultiTAA-specific T cells
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 44
- Registration Number
- NCT02494167
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Early Phase 1
Completed
- Conditions
- Rheumatologic DisordersHematologic DisordersOncologic Disorders
- Interventions
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT02484053
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath